MV, I., DM, H., EM, M., KT, B., M, W., CW, P., . . . DP, C. (2024). PCDH15 dual-AAV gene therapy for deafness and blindness in Usher syndrome type 1F models. The Journal of clinical investigation, 134(23), . https://doi.org/10.1172/JCI177700
Chicago Style (17th ed.) CitationMV, Ivanchenko, et al. "PCDH15 Dual-AAV Gene Therapy for Deafness and Blindness in Usher Syndrome Type 1F Models." The Journal of Clinical Investigation 134, no. 23 (2024). https://doi.org/10.1172/JCI177700.
MLA (9th ed.) CitationMV, Ivanchenko, et al. "PCDH15 Dual-AAV Gene Therapy for Deafness and Blindness in Usher Syndrome Type 1F Models." The Journal of Clinical Investigation, vol. 134, no. 23, 2024, https://doi.org/10.1172/JCI177700.
Warning: These citations may not always be 100% accurate.